ES376528A1 - Benzodiazepine derivatives and manufacture thereof - Google Patents

Benzodiazepine derivatives and manufacture thereof

Info

Publication number
ES376528A1
ES376528A1 ES376528A ES376528A ES376528A1 ES 376528 A1 ES376528 A1 ES 376528A1 ES 376528 A ES376528 A ES 376528A ES 376528 A ES376528 A ES 376528A ES 376528 A1 ES376528 A1 ES 376528A1
Authority
ES
Spain
Prior art keywords
compound
signifies
same meaning
general formula
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES376528A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES376528A1 publication Critical patent/ES376528A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedure for the preparation of benzodiazepine derivatives of the general formula **(See formula)** in which R1 means halogen or nitro; R2 signifies phenyl, halophenyl or pyridyl; R3 signifies hydrogen, alkyl, hydroxyalkyl, acyloxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboalkoxy; R4 signifies alkoxy, haloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkyloxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl; R5 signifies hydrogen or hydroxyl; and R6 signifies hydrogen or carboalkoxy; and in the case that R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, and of the salts of these compounds, characterized by: a) reacting a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before, or a respective 4-oxide, with a compound of the general formula **(See formula)** where stands for hydrogen, alkyl, haloalkyl, carboalkoxy or acyloxyalkyl; R8 signifies alkoxy, haloalkoxy, alkylthio or alkoxyalkylthio; and X stands for halogen, O well b) reacting a compound of the general formula **(See formula)** where R1 and R2 have the same meaning as before, with a vinyl ether of the general formula CH2 = CH-O-R9 V where R9 signifies alkyl; O well **(See formula)** where R1, R2 and R5 have the same meaning as before, R10 signifies hydrogen, alkyl, hydroxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; and R11 has the same meaning as explained for R4, but one at least of the R10 and R11 substituents means a monohaloalkyl or monohaloalkoxylic group and, in the case that R5 signifies hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, with a monoalkylamine or dialkylamine; O well d) alkylating a compound of the general formula **(See formula)** where R1 and R2 have the same meaning as before; R12 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio or aminoalkoxy; R13 signifies hydrogen, alkyl, monoalkylaminoalkyl, dialkylaminoalkyl or aminoalkyl, but one of at least one of the substituents R12 and R13 signifies an aminoalkoxy, monoalkylaminoalkoxy, aminoalkyl or monoalkylaminoalkyl group, or a respective 4-oxide; O well **(See formula)** where R1 and R2 have the same meaning as before; R14 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio or a protected monoalkylaminoalkoxy group; and R15 means hydrogen, alkyl, monoalkylaminoalkyl, dialkylaminoalkyl, acyloxyalkyl or a protected monoalkylaminoalkyl group, but one of at least one of the R14 substituents, and R15 means a protected monoalkylaminoalkoxy or monoalkylaminoalkyl group, or of a respective 4-oxide, the protecting group; O well f) in a compound of the general formula **(See formula)** where R1, R2, R5 and R6 have the same meaning as before, but also, in the case of R5 meaning hydrogen, the nitrogen atom in position 4 can carry an oxygen atom; R16 stands for alkoxy, monohaloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy, or alkylthio; and R17 stands for hydrogen, alkyl, hydroxyalkyl, monohaloalkyl, carboalkoxy, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl, but one at least of R16 and R17 substituents means monohaloalkoxy or monohaloalkyl, replacing aliphatically linked halogen atoms with hydroxy groups; O well g) in a compound of the general formula **(See formula)** where R1, R2, R5 and R6 have the same meaning as before; R18 signifies alkylthio; and R19 means hydrogen, alkyl, hydroxyalkyl, haloalkyl, carboalkoxy or acyloxyalkyl, but in case R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, oxidize the alkylthio group converting it into an alkylsulfinyl or alkylsulfonyl group ; O well h) cyclizing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before; O well i) hydrolyzing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before, while R20 signifies an acyl group; O well j) deoxygenate a compound of the general formula **(See formula)** where R1, R2, R3 and R6 have the same meaning as before, while R21 stands for alkoxy, haloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy or alkylthio; O well k) dehydrating a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R22 stands for alkoxy, dialkylaminoalkoxy, alkoxyalkoxy or alkylthio; and R23 signifies hydrogen, alkyl, carboalkoxy, dialkylaminoalkyl or acyloxyalkyl; O well l) oxidizing or dehydrogenating at the 4,5 link a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R24 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy or alkoxyalkoxy; and R25 signifies hydrogen, alkyl, hydroxyalkyl, carboalkoxy, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; O well m) saponifying and decarboxylating a compound of the general formula **(See formula)** where R1, R2, R4 and R5 have the same meaning as before; R26 means alkyl, R27 signifies hydrogen, alkyl, hydroxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; and in the case that R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom; O well n) oxidizing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R26 have the same meaning as before, to convert it to the 3-hydroxy compound; O well o) make it a compound of the general formula **(See formula)** where R1, R2, R6 and R25 have the same meaning as before, R28 means acyl; and R29 means alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy or alkylthio, with a base, in the respective compound 4,5 dehydro; O well p) become a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R30 signifies a mesyl or tosylic group; R31 signifies hydrogen, alkyl, hydroxyalkyl, carboalkoxy, dialkylaminoalkyl or acyloxyalkyl; and R32 signifies alkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, with a strong base, in the respective 4,5-dehydro compound; O well q) rearranging a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before, converting it into the respective 4,5-dehydro compound; O well r) treating a compound of the general formula where R1, R2 and R6 have the same meaning as before, R40 represents hydroxyalkyl and R41 represents alkoxy, haloalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, or a respective 4-oxide, with an acylating agent; O well s) in a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before, R42 represents haloalkyl and R43 represents alkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, or a respective 4-oxide, converting the aliphatically linked halogen atom to an acyloxylic group; and/or t) if desired, converting a resulting compound to a salt. (Machine-translation by Google Translate, not legally binding)
ES376528A 1969-02-14 1970-02-13 Benzodiazepine derivatives and manufacture thereof Expired ES376528A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH225569A CH562220A5 (en) 1969-02-14 1969-02-14

Publications (1)

Publication Number Publication Date
ES376528A1 true ES376528A1 (en) 1972-04-16

Family

ID=4229492

Family Applications (1)

Application Number Title Priority Date Filing Date
ES376528A Expired ES376528A1 (en) 1969-02-14 1970-02-13 Benzodiazepine derivatives and manufacture thereof

Country Status (23)

Country Link
AT (10) AT302322B (en)
BE (1) BE745852A (en)
BR (1) BR6915093D0 (en)
CA (1) CA971960A (en)
CH (1) CH562220A5 (en)
CS (1) CS159260B2 (en)
DE (1) DE2005508A1 (en)
DK (1) DK137899B (en)
DO (1) DOP1970001703A (en)
ES (1) ES376528A1 (en)
FI (1) FI49965C (en)
FR (1) FR2034550B1 (en)
GB (5) GB1306454A (en)
IE (2) IE33988B1 (en)
IL (2) IL33821A (en)
IS (1) IS1906A7 (en)
NL (1) NL156401B (en)
NO (2) NO128328B (en)
OA (1) OA03435A (en)
PL (1) PL80826B1 (en)
RO (5) RO57030A (en)
SE (1) SE358393B (en)
SU (11) SU402219A3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787117A (en) * 1971-08-04 1973-02-05 Hoffmann La Roche BENZODIAZEPINE DERIVATIVES
JPS4867288A (en) * 1971-12-14 1973-09-13
US3932637A (en) * 1974-07-22 1976-01-13 Sumitomo Chemical Company, Limited Methods and compositions for improving the feed intake of meat producing animals
CA1163266A (en) * 1980-07-31 1984-03-06 Albert E. Fischli Benzodiazepine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3136815A (en) * 1959-12-10 1964-06-09 Hoffmann La Roche Amino substituted benzophenone oximes and derivatives thereof

Also Published As

Publication number Publication date
SU517258A3 (en) 1976-06-05
BE745852A (en) 1970-08-12
SU404253A3 (en) 1973-10-26
AT302320B (en) 1972-10-10
CA971960A (en) 1975-07-29
DE2005508A1 (en) 1970-08-27
IS1906A7 (en) 1970-08-15
GB1306452A (en) 1973-02-14
SU415880A3 (en) 1974-02-15
SU430552A3 (en) 1974-05-30
BR6915093D0 (en) 1973-03-08
GB1306454A (en) 1973-02-14
IL42330A0 (en) 1973-07-30
RO57030A (en) 1975-01-15
FR2034550B1 (en) 1974-02-22
GB1306453A (en) 1973-02-14
SU428603A3 (en) 1974-05-15
GB1306455A (en) 1973-02-14
RO57160A (en) 1974-12-11
PL80826B1 (en) 1975-08-30
NO128328B (en) 1973-10-29
OA03435A (en) 1971-03-30
IL33821A (en) 1974-05-16
AT299208B (en) 1972-06-12
DK137899B (en) 1978-05-29
IL33821A0 (en) 1970-04-20
IE33988L (en) 1970-08-14
DK137899C (en) 1978-10-30
GB1306451A (en) 1973-02-14
AT302316B (en) 1972-10-10
FR2034550A1 (en) 1970-12-11
SU431673A3 (en) 1974-06-05
AT302318B (en) 1972-10-10
AT302317B (en) 1972-10-10
AT302323B (en) 1972-10-10
RO58075A (en) 1975-06-15
AT302319B (en) 1972-10-10
SU497774A3 (en) 1975-12-30
AT302321B (en) 1972-10-10
DOP1970001703A (en) 1975-02-14
NL7002084A (en) 1970-08-18
CH562220A5 (en) 1975-05-30
NO128110B (en) 1973-10-01
IE33991B1 (en) 1974-12-30
FI49965C (en) 1975-11-10
CS159260B2 (en) 1974-12-27
RO57161A (en) 1974-12-11
SE358393B (en) 1973-07-30
NL156401B (en) 1978-04-17
IE33988B1 (en) 1974-12-30
RO57028A (en) 1974-12-11
SU453841A3 (en) 1974-12-15
SU406360A3 (en) 1973-11-05
SU402219A3 (en) 1973-10-12
AT301555B (en) 1972-09-11
SU421195A3 (en) 1974-03-25
SU406359A3 (en) 1973-11-05
AT302322B (en) 1972-10-10
FI49965B (en) 1975-07-31

Similar Documents

Publication Publication Date Title
NO954072L (en) Water-soluble camptothecin derivatives, processes for their preparation and their use as antitumor agents
AR013358A1 (en) COMPOUNDS DERIVED FROM EPOTILONE (DERIVATIVES FROM AZA CICLOHEXADECANO), USEFUL IN THERAPEUTICS.
ES433835A1 (en) Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
NO159172C (en) NEW N-ALKYL NORSCOPINS.
SE7602122L (en) NEW PIPERAZINYLIMINORIFAMYCINS AND WAYS TO PRODUCE THE SAME
SE7509861L (en) PROCEDURE FOR THE PREPARATION OF N-ACYLAMINO-ALFA-ARYLACETAMIDO-CEPHALOSPORINES
GB1503077A (en) Quaternary imidazolium compounds and their use as microbicides
ES376528A1 (en) Benzodiazepine derivatives and manufacture thereof
ES411380A1 (en) Pyrazoline compounds having insecticidal activity
ES278111A1 (en) A procedure for the manufacture of replaced hydrazine derivatives (Machine-translation by Google Translate, not legally binding)
ES457872A1 (en) 2-methoxy-benzamide derivatives
ES462305A1 (en) Substituted 4-phenylurazoles and their use in agricultural fungicide compositions
GB1104773A (en) Process for the preparation of 5-substituted oxazolidones-(2)
DE3569528D1 (en) Penem derivatives, methods of producing them, their use and pharmaceutical compositions
EP0028936A3 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
ES404744A1 (en) Cephalosporin derivatives
ES378467A1 (en) Novel aminopiperidines, processes for their preparation, and compositions incorporating them
ES451466A1 (en) 5-thiazole-methane-amines, and their use as antilipolytics
ES315051A1 (en) Method for the preparation of derivatives of natural isoflavones. (Machine-translation by Google Translate, not legally binding)
ES316314A1 (en) Procedure for the production of derivatives of podofilotoxina. (Machine-translation by Google Translate, not legally binding)
ATE91033T1 (en) PHOTOCHROMIC COMPOSITION AND ARTICLES CONTAINING SUCH COMPOSITION.
ES442441A1 (en) 1,4-Oxathiino{8 2,3-c{9 pyrrole derivatives
ES306852A1 (en) Improvements introduced in the preparation of herbicidal compositions. (Machine-translation by Google Translate, not legally binding)
ES418331A1 (en) Quinoline derivatives processes for their preparation and compo sitions incorporating them
KR830007634A (en) Preparation of N-pyrrolyl pyridazineamine